Login / Signup

Effect of Dupilumab on Laboratory Parameters in Adolescents with Atopic Dermatitis: Results from a Randomized, Placebo-Controlled, Phase 3 Clinical Trial.

Elaine C SiegfriedThomas BieberEric L SimpsonAmy S PallerLisa A BeckMark BoguniewiczLynda C SchneiderFaisal A KhokharZhen ChenRandy PrescillaPaola Mina-OsorioAshish Bansal
Published in: American journal of clinical dermatology (2021)
ClinicalTrials.gov: NCT03054428. Video abstract: Effect of Dupilumab on Laboratory Parameters in Adolescents with Atopic Dermatitis: Results from a Randomized Placebo-Controlled Phase 3 Clinical Trial (MP4 175137 KB).
Keyphrases
  • atopic dermatitis
  • double blind
  • placebo controlled
  • clinical trial
  • phase ii
  • young adults
  • phase iii
  • study protocol
  • physical activity
  • open label
  • phase ii study
  • squamous cell carcinoma